Is Chugai Pharmaceutical (TSE:4519) Still Attractively Priced After Its Strong Multi Year Run [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Wondering if Chugai Pharmaceutical's share price still offers value after a strong multi year run? This article unpacks how the current price compares with several valuation checks. The stock last closed at ¥8,585, with a 3.2% decline over the past week and an 8.3% decline over the past month. It is still up 0.8% year to date and 34.6% over 1 year, and very large over 3 and 5 years. Recent coverage has focused on Chugai Pharmaceutical's position within the pharmaceuticals space in Japan and how investors are reacting to its long term performance and fundamentals. This context helps explain why short term pullbacks are drawing interest from investors who are reassessing what a fair price might look like. On Simply Wall St's 6 point valuation checklist, Chugai Pharmaceutical currently scores 3 out of 6. Next you will see how each valuation approach views the stock and, by the end, a more complete way to think about its valuation beyond any single metric. Find out why Chugai Pha
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche launches new Elevidys study after feedback from European regulator [Yahoo! Finance]Yahoo! Finance
- Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) PlatformBusiness Wire
- Eli Lilly Launches Foundayo: A Novel Oral GLP-1 Weight Management Therapy [TheStreet.com]TheStreet.com
- C4 Therapeutics inks new deal with Roche for degrader-antibody conjugates [Seeking Alpha]Seeking Alpha
- Two more pharmaceutical companies, Abbvie and Genentech, to officially launch on TrumpRx [CBS News]CBS News